CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc., a leader in both the Companion Diagnostics and Molecular Diagnostics liquid biopsy space, today announced the appointment of Elizabeth Cormier-May as Head of Commercial Diagnostics. Elizabeth joined Exosome Diagnostics in May to build the infrastructure and define the strategy for the launch of the company’s flagship diagnostic, ExoDx® Prostate(IntelliScore) or EPI, into the urology market. EPI complements an existing ExoDx Lung(ALK) test, and both are the beginning to an extensive diagnostic offering of products within the company’s diagnostic oncology division.
